-Primary cancer tissues express less CD44 and CD133 compared with metastatic cancer tissues. -CD44 increases Oct4 expression through ERK pathway in a positive feedback loop and maintains the stemness of gastric cancers. -CD44 might be a driving factor in the development of CSCs in addition to being a surface marker. The gene discussed is PROM1; the disease is gastric cancer.